Supply of Cytek Aurora Evo Flow Cytometer System

The contract seeks the procurement and delivery of a new Cytek Aurora Evo flow cytometer to replace an existing Cytek Northern Lights system through a trade-in arrangement, enabling high-complexity flow cytometric analyses critical for clinical trials and patient monitoring. The acquisition is intended to enhance analytical precision and throughput in a clinical research environment, with the new system required to meet stringent performance standards for diagnostic and research applications. The existing Northern Lights instrument will be traded in as part of the transaction, ensuring seamless technology transition without additional disposal burdens. This is a small business set-aside subcontract under the SBA program, classified under NAICS code 334516 for medical diagnostic equipment manufacturing, and is issued by the National Institutes of Health through the Department of Health and Human Services. The place of performance is designated as Bethesda, Maryland, with a response deadline of July 18, 2026, and the solicitation was posted on July 8, 2026. The contract structure ensures that only qualified small businesses may respond, promoting federal procurement goals for small business participation while maintaining technical integrity for high-stakes laboratory operations.